Vidyya Medical News Service
*
Volume 6 Issue 5 Published - 14:00 UTC 08:00 EST 5-Jan-2004 Next Update - 14:00 UTC 08:00 EST 6-Jan-2004
little clear gif used for spacer
.
*

No sudden movements, please.
Scientists have proof that people who seldom take exercise may be best off avoiding sudden bursts of vigorous physical activity. University of Essex researchers found infrequent strenuous exercise poses a serious risk of a heart attack. It keeps the heart racing for a long period - extending the time when problems could occur.  more

*
Cocktails, anyone? Men with enlarged prostates should be given two drugs instead of one, as part of their treatment.
Men with enlarged prostates should be given a cocktail of drugs as part of their treatment, a study suggests. One in three men over the age of 50 suffer from benign prostatic hyperplasia - a non-cancerous condition that causes them to urinate frequently. Many receive one of two drugs to help treat the condition, namely finasteride or doxazosin. But a five-year study involving more than 3,000 men in the US suggests they would fare better if they took both.  more

*
Prescribing information: Proscar (finasteride)
Proscar (finasteride) lowers levels of a key hormone called DHT (dihydrotestosterone), which is a major cause of prostate growth. Lowering DHT leads to shrinkage of the enlarged prostate gland in most men. This can lead to gradual improvement in urine flow and symptoms over the next several months. Proscar can help reduce the risk of developing a sudden inability to pass urine and the need for surgery.  more

 


*
Prescribing information: Cardura (doxazosin)
Cardura (doxazosin) is used to treat high blood pressure. It works by relaxing the blood vessels, so that blood can flow more easily through the body. It also is used to treat benign prostatic hyperplasia (BPH) in men. It works by relaxing the muscles of the bladder and prostate.  more

*
Diagnosticians would do well to raise the bar when testing high-functioning people for pre-clinical signs of Alzheimer's disease
Diagnosticians would do well to raise the bar when testing high-functioning people for pre-clinical signs of Alzheimer's disease, according to a new study. Higher test cutoffs, rather than the standard group average, more accurately predicted how many highly intelligent people would deteriorate over time. This finding is reported in the January issue of Neuropsychology, which is published by the American Psychological Association (APA). more

*
Pharmaceutical "metal binder" could put the breaks on Alzheimer symptoms
Clioquinol, a drug that binds to metal compounds and clears them from the body, may slow cognitive decline in patients severely affected by Alzheimer's disease (AD), suggests a study appearing in the Archives of Neurology for December 2003.  more

*
Alzheimer’s Association statement on a study of clioquinol targeting Aß amyloid deposition and toxicity in alzheimer’s disease from Archives Of Neurology, December 2003
This statement is from William Thies, Ph.D., vice president, Medical and Scientific Affairs, Alzheimer's Association regarding an article appearing in the December 2003 issue of the Archives of Neurology.  more

 
little clear gif used for a space